Clinomics Inc. announced a private placement of series 2 bearer-type non-guaranteed private placement convertible bond for the gross proceeds of KRW 15,000,000,000 on December 15, 2023. The transaction will include participation from new investors Pound Equity Partners Ltd and Busan Equity Partners Co., Ltd. for KRW 7,500,000,000 each. The bonds carry a coupon rate of 3% and maturity rate of 5% and will mature on February 22, 2027.

The bonds are convertible into 5,795,981 common shares at a conversion value of KRW 2,588 per share from February 22, 2025 to January 21, 2027. The bonds are restricted to a hold period of 1 year from the date of bond issuance. The transaction is expected tp close on February 22, 2024.